The Latest Cardiac and Vascular News
Accelerated Commercialization Due to COVID-19 Will Enable Providers to Offer Optimized, Efficient Care BRISBANE, Calif., July 15, 2020 /PRNewswire/ — Caption Health, a leading medical artificial intelligence (AI) company, closed its Series B funding round with $53 million to further develop and commercialize its FDA-cleared, AI-guided ultrasound technology that expands patient access to high-quality […]
ENGLEWOOD, Colo., July 14, 2020 /PRNewswire/ — Zynex, Inc. (“Zynex”) (Nasdaq: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today the pricing of its previously announced underwritten public offering of an aggregate of 2,500,000 shares of its […]
Company Sees Record Growth for Its Technology Powered by Deep Learning and Artificial Intelligence MINNEAPOLIS, July 15, 2020 /PRNewswire/ — Preventice Solutions, a leader in digital healthcare solutions and remote cardiac monitoring services powered by deep learning and artificial intelligence (AI), today announced that it has raised $137M in a Series B financing to accelerate […]
PLANO, Texas, July 15, 2020 (GLOBE NEWSWIRE) — Integer Holdings Corporation (“Integer”) (NYSE: ITGR), a leading medical device outsource manufacturer, announced that the United States Court of Appeals for the Federal Circuit affirmed yesterday, in all respects, the judgment in its favor granted in the United States District Court for […]
Robert S. White Joins Board of Directors SANTA CLARA, Calif., July 14, 2020 (GLOBE NEWSWIRE) — Cardiva Medical, Inc, an innovator in the field of vascular closure, today announced the completion of a $45 million equity financing round. The equity round included new investor EW Healthcare Partners in addition to […]
NEW HOPE, Pa., July 13, 2020 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company focused on developing transformative therapeutic products for large unmet needs in procedure-based medicine, today announced the appointment of Jagdish Parasrampuria M.Pharm., Ph.D., as Vice President of Pharmaceutical Development. Dr. Parasrampuria […]
$250 Million in Committed Capital to Cytokinetics; Additional $200 Million in Development and Commercialization Milestone Payments Ji Xing Pharmaceuticals to Develop & Commercialize in China RTW Provides Access to Capital to Cytokinetics to Fund Global Development in Exchange for Potential Royalties and Agrees to Purchase Royalty on Mavacamten Company to Host […]
ABBOTT PARK, Ill., July 13, 2020 /PRNewswire/ — Abbott (NYSE: ABT) announced today it has reached an agreement with Edwards Lifesciences Corporation to settle all outstanding patent disputes between the companies in cases related to transcatheter mitral and tricuspid repair products. The agreement will result in the dismissal of all pending cases or appeals […]
SUNNYVALE, Calif., July 09, 2020 (GLOBE NEWSWIRE) — Silk Road Medical, Inc. (Nasdaq: SILK), a company focused on reducing the risk of stroke and its devastating impact, today announced that Andrew Davis has been promoted to Chief Commercial Officer. In this newly created role, Mr. Davis will oversee Silk Road […]
TARRYTOWN, N.Y., July 8, 2020 /PRNewswire/ — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it will report its second quarter 2020 financial and operating results on Wednesday, August 5, 2020, before the U.S. financial markets open. The Company will host a conference call and simultaneous webcast at 8:30 AM Eastern Time that day. Conference Call InformationTo access […]
